471 related articles for article (PubMed ID: 21860375)
1. An in vitro system to study tumor dormancy and the switch to metastatic growth.
Barkan D; Green JE
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21860375
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton.
Barkan D; Kleinman H; Simmons JL; Asmussen H; Kamaraju AK; Hoenorhoff MJ; Liu ZY; Costes SV; Cho EH; Lockett S; Khanna C; Chambers AF; Green JE
Cancer Res; 2008 Aug; 68(15):6241-50. PubMed ID: 18676848
[TBL] [Abstract][Full Text] [Related]
3. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment.
Barkan D; El Touny LH; Michalowski AM; Smith JA; Chu I; Davis AS; Webster JD; Hoover S; Simpson RM; Gauldie J; Green JE
Cancer Res; 2010 Jul; 70(14):5706-16. PubMed ID: 20570886
[TBL] [Abstract][Full Text] [Related]
4. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.
Naumov GN; Townson JL; MacDonald IC; Wilson SM; Bramwell VH; Groom AC; Chambers AF
Breast Cancer Res Treat; 2003 Dec; 82(3):199-206. PubMed ID: 14703067
[TBL] [Abstract][Full Text] [Related]
5. An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells.
Narkhede AA; Crenshaw JH; Crossman DK; Shevde LA; Rao SS
Acta Biomater; 2020 Apr; 107():65-77. PubMed ID: 32119920
[TBL] [Abstract][Full Text] [Related]
6. Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces.
Liu R; Zhao Y; Su S; Kwabil A; Njoku PC; Yu H; Li X
Cancer Lett; 2024 Jun; 591():216899. PubMed ID: 38649107
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
8. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
9. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
Naumov GN; MacDonald IC; Weinmeister PM; Kerkvliet N; Nadkarni KV; Wilson SM; Morris VL; Groom AC; Chambers AF
Cancer Res; 2002 Apr; 62(7):2162-8. PubMed ID: 11929839
[TBL] [Abstract][Full Text] [Related]
10. KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?
Harihar S; Welch DR
Cancer Metastasis Rev; 2023 Mar; 42(1):183-196. PubMed ID: 36720764
[TBL] [Abstract][Full Text] [Related]
11. Regulation of dormancy during tumor dissemination: the role of the ECM.
Mukherjee A; Bravo-Cordero JJ
Cancer Metastasis Rev; 2023 Mar; 42(1):99-112. PubMed ID: 36802311
[TBL] [Abstract][Full Text] [Related]
12. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.
Almog N; Ma L; Schwager C; Brinkmann BG; Beheshti A; Vajkoczy P; Folkman J; Hlatky L; Abdollahi A
PLoS One; 2012; 7(8):e44001. PubMed ID: 22952847
[TBL] [Abstract][Full Text] [Related]
13. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
14. A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.
Clark AM; Kumar MP; Wheeler SE; Young CL; Venkataramanan R; Stolz DB; Griffith LG; Lauffenburger DA; Wells A
Mol Cell Proteomics; 2018 Apr; 17(4):619-630. PubMed ID: 29353230
[TBL] [Abstract][Full Text] [Related]
15. The dormancy dilemma: quiescence versus balanced proliferation.
Wells A; Griffith L; Wells JZ; Taylor DP
Cancer Res; 2013 Jul; 73(13):3811-6. PubMed ID: 23794703
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.
Barkan D; Green JE; Chambers AF
Eur J Cancer; 2010 May; 46(7):1181-8. PubMed ID: 20304630
[TBL] [Abstract][Full Text] [Related]
17. Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.
Rossari F; Zucchinetti C; Buda G; Orciuolo E
Cell Oncol (Dordr); 2020 Apr; 43(2):155-176. PubMed ID: 31392521
[TBL] [Abstract][Full Text] [Related]
18. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
20. Cell dormancy and tumor refractory.
Wang K; Jiang W; Cheng C; Li Y; Tu M
Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
